The Environmental Determinants of Islet Autoimmunity (ENDIA) study is a national longitudinal prospective cohort study which aims to identify the environmental factors that drive the development of type 1 diabetes (T1D) in at-risk individuals.1 Recruitment commenced in 2013 and is proceeding at eight hospitals across Adelaide, Sydney, Melbourne, Brisbane, Perth and Geelong, covering approximately 64% of the general population.2 In 2016, ENDIA launched the Regional Participation Program (RPP) to facilitate the participation of eligible families outside these cities.
- 1. Penno MAS, Couper JJ, Craig ME, et al. Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatrics 2013; 13: 124.
- 2. Australian Bureau of Statistics [website]. Regional population growth, Australia, 2014–15 (Cat. No. 3218.0). Canberra: ABS; 2016. http://www.abs.gov.au/AUSSTATS/abs@.nsf/mf/3218.0 (accessed May 2016).
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.